Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Microbiome-based therapy for recurrent CDI hits mark in patients with comorbidities
The investigational microbiota-based live biotherapeutic RBX2660 is safe and averts repeat episodes of Clostridioides difficile infection (CDI) across patient populations with comorbid conditions, as shown in a study presented at Digestive Disease Week (DDW) 2022.
Microbiome-based therapy for recurrent CDI hits mark in patients with comorbidities
07 Jun 2022Does IBS elevate long-term risk of cancer?
People with irritable bowel syndrome (IBS) are not at increased overall risk of cancer relative to the general population, reveals a study. On the contrary, those with IBS appear to have a lower risk of incident colorectal cancer (CRC) and cancer-specific mortality.
Does IBS elevate long-term risk of cancer?
07 Jun 2022Frail women at risk of complications, repeat procedure after sling surgery
Frailty is associated with a higher relative risk of 30-day complications, 1-year mortality, and repeat procedures for persistent incontinence or obstructed voiding at 1 year after sling surgery in older adults, suggests a recent study.
Frail women at risk of complications, repeat procedure after sling surgery
07 Jun 2022High-dose iberdomide shows promise in phase II SLE trial
In a phase II trial evaluating three doses of the high-affinity cereblon modulator iberdomide, the 0.45-mg dose demonstrated superiority over placebo for individuals with active, moderate-to-severe systemic lupus erythematosus (SLE).
High-dose iberdomide shows promise in phase II SLE trial
07 Jun 2022H. pylori eradication suppresses long-term gastric cancer risk
Helicobacter pylori eradication treatment leads to large reductions in the risk of gastric cancer and lower rates of associated deaths over 10 years of follow-up, according to a recent meta-analysis.
H. pylori eradication suppresses long-term gastric cancer risk
07 Jun 2022Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate
A recent cross-sectional questionnaire study has shown that women with postmenopausal bleeding (PMB) would select transvaginal sonography to measure endometrial thickness (TVS-ET) over gold-standard hysteroscopy with biopsy if TVS-ET achieved a median endometrial cancer detection rate of 95.0 percent.